CDK4 and non-small cell lung carcinoma: Several clinical trials tested CDK4/6 inhibitors in patients with advanced-stage NSCLC (NCT02154490; NCT01291017; NCT02152631; NCT02079636; NCT01394016; and NCT02411591).